Advertisement

Chronic Opioid Use and Sleep Disorders

  • Shahrokh Javaheri
    Correspondence
    Corresponding author. 10535 Montgomery Road, Suite 200, Cincinnati, OH 45242.
    Affiliations
    Division of Pulmonary and Sleep Medicine, Bethesda North Hospital, 10535 Montgomery Road, Suite 200, Cincinnati, OH 45242, USA

    Division of Medicine, The Ohio State University, 181 Taylor Avenue, Columbus, OH 43203, USA
    Search for articles by this author
  • Michelle Cao
    Affiliations
    Division of Pulmonary, Allergy, Critical Care Medicine, Stanford University School of Medicine, 300 Pasteur Drive, H3143, Stanford, CA 94305, USA

    Division of Sleep Medicine, Stanford University School of Medicine, 450 Broadway Street, Redwood City, CA 94063, USA
    Search for articles by this author
Published:September 07, 2022DOI:https://doi.org/10.1016/j.jsmc.2022.06.008

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Sleep Medicine Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • American Academy of Pain Medicine and the American Pain Society
        The use of opioids for the treatment of chronic pain. A consensus statement from the American Academy of Pain Medicine and the American Pain Society.
        Clin J Pain. 1997; 13: 6-8
        • Han B.
        • Compton W.M.
        • Blanco C.
        • et al.
        Prescription opioid use, misuse, and use disorders in U.S. Adults: 2015 national survey on drug use and health.
        Ann Intern Med. 2017; 167: 293-301
        • Ballantyne J.C.
        Opioid for the treatment of chronic pain: mistakes made, lessons learned, and future directions.
        Anesth Analg. 2017; 125: 1769-1778
        • Rutkow J.
        • Vernick J.S.
        Emergency legal authority and the opioid crisis.
        N Engl J Med. 2017; 377: 2512-2514
        • Dowell D.
        • Haegerich T.
        • Chou R.
        • et al.
        CDC guideline for prescribing opioids for chronic pain - United States, 2016.
        MMWR Recomm Rep. 2016; 65: 1-49
        • Teichtahl H.
        • Prodromidis A.
        • Miller B.
        • et al.
        Sleep disordered breathing in stable methadone programme patients: a pilot study.
        Addiction. 2001; 96: 395-403
        • Wang D.
        • Teichtahl M.
        • Drummer O.
        • et al.
        Central sleep apnea in stable methadone maintenance treatment patients.
        Chest. 2005; 128: 1348-1356
        • Weaver T.E.
        • Laizner A.M.
        • Evans L.K.
        • et al.
        An instrument to measure functional status outcomes for disorders of excessive sleepiness.
        Sleep. 1997; 20: 835-843
        • Patten S.B.
        • Fick G.H.
        Clinical interpretation of the mini-mental state.
        Gen Hosp Psychiatry. 1993; 15: 254-259
        • Fischer B.
        • Murphy Y.
        • Kurdyak P.
        • et al.
        Depression - a major but neglected consequence contributing to the health toll from prescription opioids?.
        Psychiatry Res. 2016; 243: 331-334
        • Scherrer J.F.
        • Salas J.
        • Copeland L.A.
        • et al.
        Increased risk of depression recurrence after initiation of prescription opioids in non-cancer pain patients.
        J Pain. 2016; 17: 473-482
        • Merrill J.O.
        • Von Korff M.
        • Banta-Green C.J.
        • et al.
        Prescribed opioid difficulties, depression and opioid dose among chronic opioid therapy patients.
        Gen Hosp Psychiatry. 2012; 34: 581-587
        • Scherrer J.F.
        • Svrakic D.M.
        • Freedland K.E.
        • et al.
        Prescription opioid analgesics increase the risk of depression.
        J Gen Intern Med. 2014; 29: 491-499
        • Dimsdale J.E.
        • Norman D.
        • DeJardin D.
        • et al.
        The ef- fect of opioids on sleep architecture.
        J Clin Sleep Med. 2007; 3: 33-36
        • Xiao L.
        • Tang Y.
        • Smith A.K.
        • et al.
        Nocturnal sleep architecture disturbances in early methadone treatment patients.
        Psychiatry Res. 2010; 179: 91-95
        • Mogri M.
        • Desai H.
        • Webster L.
        • et al.
        Hypoxemia in patients on chronic opiate therapy with and without sleep apnea.
        Sleep Breath. 2009; 13: 49-57
        • Webster L.R.
        • Choi Y.
        • Desai H.
        • et al.
        Sleep-disordered breathing and chronic opioid therapy.
        Pain Med. 2008; 9: 425-432
        • Sharkey K.M.
        • Kurth M.E.
        • Anderson B.J.
        • et al.
        Obstructive sleep apnea is more common than central sleep apnea in methadone maintenance patients with subjective sleep complaints.
        Drug Alcohol Depend. 2010; 108: 77-83
        • Correa D.
        • Farney R.J.
        • Chung F.
        • et al.
        Chronic opioid use and central sleep apnea: a review of the prevalence, mechanisms, and perioperative considerations.
        Anesth Analg. 2015; 120: 1273-1285
        • Walker J.M.
        • Farney R.J.
        • Rhondeau S.M.
        • et al.
        Chronic opioid use is a risk factor for the development of central sleep apnea and ataxic breathing.
        J Clin Sleep Med. 2007; 3: 455-461
        • Gavidia R.
        • Emenike A.
        • Meng A.
        • et al.
        The influence of opioids and nonopioid central nervous system active medications on central sleep apnea: a case-control study.
        J Clin Sleep Med. 2021; 17: 55-60
        • Chowdhuri S.
        • Javaheri S.
        Sleep disordered breathing caused by chronic opioid use: diverse manifestations and their management.
        Sleep Med Clin. 2017; 12: 573-586
        • Smith J.C.
        • Ellenberger H.H.
        • Ballanyi K.
        • et al.
        Pre-Bot- zinger complex: a brainstem region that may generate respiratory rhythm in mammals.
        Science. 1991; 254: 726-729
        • Feldman J.L.
        • Del Negro C.A.
        Looking for inspiration: new perspectives on respiratory rhythm.
        Nat Rev Neurosci. 2006; 7: 232-242
        • Gray P.A.
        • Janczewski W.A.
        • Mellen N.
        • et al.
        Normal breathing requires preBotzinger complex neurokinin-1 receptor-expressing neurons.
        Nat Neurosci. 2001; 4: 927-930
        • Gray P.A.
        • Rekling J.C.
        • Bocchiaro C.M.
        • et al.
        Modulation of respiratory frequency by peptidergic input to rhythmogenic neurons in the preBotzinger complex.
        Science. 1999; 286: 1566-1568
        • McKay L.C.
        • Janczewski W.A.
        • Feldman J.L.
        Sleep- disordered breathing after targeted ablation of pre- Botzinger complex neurons.
        Nat Neurosci. 2005; 8: 1142-1144
        • McKay L.C.
        • Feldman J.L.
        Unilateral ablation of pre- Botzinger complex disrupts breathing during sleep but not wakefulness.
        Am J Respir Crit Care Med. 2008; 178: 89-95
        • Edwards B.A.
        • White D.P.
        Control of the pharyngeal musculature during wakefulness and sleep: implications in normal controls and sleep apnea.
        Head Neck. 2011; 33: S37-S45
        • Guilleminault C.
        • Cao M.
        • Yue H.J.
        • et al.
        Obstructive sleep apnea and chronic opioid use.
        Lung. 2010; 188: 459-468
        • Farney R.J.
        • Walker J.M.
        • Boyle K.M.
        • et al.
        Adaptive servoventilation (ASV) in patients with sleep disordered breathing associated with chronic opioid medica tions for non-malignant pain.
        J Clin Sleep Med. 2008; 4: 311-319
        • Javaheri S.
        • Malik A.
        • Smith J.
        • et al.
        Adaptive pressure support servoventilation: a novel treatment for sleep apnea associated with use of opioids.
        J Clin Sleep Med. 2008; 4: 305-310
        • Allam J.S.
        • Olson E.J.
        • Gay P.C.
        • et al.
        Efficacy of adaptive servoventilation in treatment of complex and central sleep apnea syndromes.
        Chest. 2007; 132: 1839-1846
        • Javaheri S.
        • Patel S.
        Opioids cause central and complex sleep apnea in humans and reversal with discontinuation: a plea for detoxification.
        J Clin Sleep Med. 2017; 13: 829-833
        • Davis M.J.
        • Livingston M.
        • Scharf S.M.
        Reversal of central sleep apnea following discontinuation of opioids.
        J Clin Sleep Med. 2012; 8: 579-580
        • Farney R.J.
        • McDonald A.M.
        • Boyle K.M.
        • et al.
        Sleep disordered breathing in patients receiving therapy with buprenorphine/naloxone.
        Eur Respir J. 2013; 42: 394-403
        • Glidewell R.N.
        • Orr W.C.
        • Imes N.
        Acetazolamide as an adjunct to CPAP treatment: a case of complex sleep apnea in a patient on long-acting opioid therapy.
        J Clin Sleep Med. 2009; 5: 63-64
        • Ren J.
        • Poon B.Y.
        • Tang Y.
        • et al.
        Ampakines alleviate respiratory depression in rats.
        Am J Respir Crit Care Med. 2006; 174: 1384-1391
        • Ren J.
        • Greer J.J.
        Modulation of perinatal respiratory rhythm by GABA(A)-and glycine receptor- mediated chloride conductances.
        Adv Exp Med Biol. 2008; 605: 149-153
        • Greer J.J.
        • Ren J.
        Ampakine therapy to counter fentanyl-induced respiratory depression.
        Respir Physiol Neurobiol. 2009; 168: 153-157
        • Ren J.
        • Ding X.
        • Funk G.D.
        • et al.
        Ampakine CX717 protects against fentanyl-induced respiratory depression and lethal apnea in rats.
        Anesthesiology. 2009; 110: 1364-1370
        • Ren J.
        • Lenal F.
        • Yang M.
        • et al.
        Coadministration of the AMPAKINE CX717 with propofol reduces respiratory depression and fatal apneas.
        Anesthesiology. 2013; 118: 1437-1445
        • Oertel B.G.
        • Felden L.
        • Tran P.V.
        • et al.
        Selective antagonism of opioid-induced ventilatory depression by an ampakine molecule in humans without loss of opioid analgesia.
        Clin Pharmacol Ther. 2010; 87: 204-211
        • Lorier A.R.
        • Funk G.D.
        • Greer J.J.
        Opiate-induced suppression of rat hypoglossal motoneuron activity and its reversal by ampakine therapy.
        PLoS One. 2010; 5: e8766
        • Dai W.
        • Xiao D.
        • Gao X.
        • et al.
        A brain-targeted ampakine compound protects against opioid-induced respiratory depression.
        Eur J Pharmacol. 2017; 809: 122-129
        • Chowdhuri S.
        • Ghabsha A.
        • Sinha P.
        • et al.
        Treatment of central sleep apnea in US veterans.
        J Clin Sleep Med. 2012; 8: 555-563
        • Farney R.J.
        • Walker J.M.
        • Cloward T.V.
        • et al.
        Sleep- disordered breathing associated with long-term opioid therapy.
        Chest. 2003; 123: 632-639
        • Alattar M.A.
        • Scharf S.M.
        Opioid-associated central sleep apnea: a case series.
        Sleep Breath. 2009; 13: 201-206
        • Javaheri S.
        • Goetting M.G.
        • Khayat R.
        • et al.
        The performance of two automatic servo-ventilation devices in the treatment of central sleep apnea.
        Sleep. 2011; 34: 1693-1698
        • Javaheri S.
        Positive airway pressure treatment of central sleep apnea with emphasis on heart failure, opioids, and complex sleep apnea.
        in: Berry R.B. Sleep medicine clinics. WB Saunders, Philadelphia2010: 407-417
        • Cao M.
        • Cardell C.
        • Willes L.
        • et al.
        A novel adaptive servoventilation (ASVauto) for the treatment of central sleep apnea associated with chronic use of opioids.
        J Clin Sleep Med. 2014; 10: 855-861
        • Shapiro C.M.
        • Chung S.A.
        • Wylie P.E.
        • et al.
        Home-use of servo-ventilation therapy in chronic pain patients with central sleep apnea: initial and 3-month follow up.
        Sleep Breath. 2015; 19: 1285-1292
        • Javaheri S.
        • Harris N.
        • Howard J.
        • et al.
        Adaptive servoventilation for treatment of opioid-associated central sleep apnea.
        J Clin Sleep Med. 2014; 10: 637-643
        • Reddy R.
        • Adamo D.
        • Kufel T.
        • et al.
        Treatment of opioid-related central sleep apnea with positive airway pressure: a systematic review.
        J Opioid Manag. 2014; 10: 57-62
        • Ramar K.
        • Ramar P.
        • Morgenthaler T.
        Adaptive servo- ventilation in patients with central or complex sleep apnea related to chronic opioid use and congestive heart failure.
        J Clin Sleep Med. 2012; 8: 569-576
        • Javaheri S.
        • Brown L.
        • Randerath W.
        Positive airway pressure therapy with adaptive servo-ventilation (Part 1: operational algorithms).
        Chest. 2014; 146: 514-523
        • Javaheri S.
        • Brown L.
        • Randerath W.
        Positive airway pressure therapy with adaptive servo-ventilation (Part II: clinical Applications).
        Chest. 2014; 146: 855-868
        • Katchman A.N.
        • McGroary K.A.
        • Kilborn M.J.
        • et al.
        Influence of opioid agonists on cardiac human ether-a-go-go related gene K(+) currents.
        J Pharmacol Exp Ther. 2002; 303: 688-694